Selected research
Industry Research
HIV and AIDS Diagnostics Industry Research Report 2026
Market perspective
The global HIV and AIDS Diagnostics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the HIV and AIDS Diagnostics market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the HIV and AIDS Diagnostics market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the HIV and AIDS Diagnostics market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of HIV and AIDS Diagnostics include Siemens Healthineers, Bio-Rad, Abbott Laboratories, OraSure TechnologieS, F. Hoffmann-La Roche, Hologic, Abbott, Chembio Diagnostic Systems and BD and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global HIV and AIDS Diagnostics market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to HIV and AIDS Diagnostics.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
HIV and AIDS Diagnostics Market by Company
Siemens Healthineers
Bio-Rad
Abbott Laboratories
OraSure TechnologieS
F. Hoffmann-La Roche
Hologic
Abbott
Chembio Diagnostic Systems
BD
Danaher Corporation
HIV and AIDS Diagnostics Segment by Type
Reagent Test Kit
Instrument
Others
HIV and AIDS Diagnostics Segment by Application
Hospitals
Private Diagnostic Laboratories
Academic and Research Institutes
HIV and AIDS Diagnostics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HIV and AIDS Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of HIV and AIDS Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HIV and AIDS Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of HIV and AIDS Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Reagent Test Kit
- Instrument
- Others
Applications
- Hospitals
- Private Diagnostic Laboratories
- Academic and Research Institutes
Companies covered
- Siemens Healthineers
- Bio-Rad
- Abbott Laboratories
- OraSure TechnologieS
- F. Hoffmann-La Roche
- Hologic
- Abbott
- Chembio Diagnostic Systems
- BD
- Danaher Corporation
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 HIV and AIDS Diagnostics by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Reagent Test Kit
- 2.2.3 Instrument
- 2.2.4 Others
- 2.3 HIV and AIDS Diagnostics by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals
- 2.3.3 Private Diagnostic Laboratories
- 2.3.4 Academic and Research Institutes
- 2.4 Assumptions and Limitations
3 HIV and AIDS Diagnostics Breakdown Data by Type
- 3.1 Global HIV and AIDS Diagnostics Historic Market Size by Type (2021-2026)
- 3.2 Global HIV and AIDS Diagnostics Forecasted Market Size by Type (2027-2032)
4 HIV and AIDS Diagnostics Breakdown Data by Application
- 4.1 Global HIV and AIDS Diagnostics Historic Market Size by Application (2021-2026)
- 4.2 Global HIV and AIDS Diagnostics Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global HIV and AIDS Diagnostics Market Perspective (2021-2032)
- 5.2 Global HIV and AIDS Diagnostics Growth Trends by Region
- 5.2.1 Global HIV and AIDS Diagnostics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 HIV and AIDS Diagnostics Historic Market Size by Region (2021-2026)
- 5.2.3 HIV and AIDS Diagnostics Forecasted Market Size by Region (2027-2032)
- 5.3 HIV and AIDS Diagnostics Market Dynamics
- 5.3.1 HIV and AIDS Diagnostics Industry Trends
- 5.3.2 HIV and AIDS Diagnostics Market Drivers
- 5.3.3 HIV and AIDS Diagnostics Market Challenges
- 5.3.4 HIV and AIDS Diagnostics Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top HIV and AIDS Diagnostics Players by Revenue
- 6.1.1 Global Top HIV and AIDS Diagnostics Players by Revenue (2021-2026)
- 6.1.2 Global HIV and AIDS Diagnostics Revenue Market Share by Players (2021-2026)
- 6.2 Global HIV and AIDS Diagnostics Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of HIV and AIDS Diagnostics Head Office and Area Served
- 6.4 Global HIV and AIDS Diagnostics Players, Product Type & Application
- 6.5 Global HIV and AIDS Diagnostics Manufacturers Established Date
- 6.6 Global HIV and AIDS Diagnostics Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America HIV and AIDS Diagnostics Market Size (2021-2032)
- 7.2 North America HIV and AIDS Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America HIV and AIDS Diagnostics Market Size by Country (2021-2026)
- 7.4 North America HIV and AIDS Diagnostics Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe HIV and AIDS Diagnostics Market Size (2021-2032)
- 8.2 Europe HIV and AIDS Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe HIV and AIDS Diagnostics Market Size by Country (2021-2026)
- 8.4 Europe HIV and AIDS Diagnostics Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific HIV and AIDS Diagnostics Market Size (2021-2032)
- 9.2 Asia-Pacific HIV and AIDS Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific HIV and AIDS Diagnostics Market Size by Country (2021-2026)
- 9.4 Asia-Pacific HIV and AIDS Diagnostics Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America HIV and AIDS Diagnostics Market Size (2021-2032)
- 10.2 South America HIV and AIDS Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America HIV and AIDS Diagnostics Market Size by Country (2021-2026)
- 10.4 South America HIV and AIDS Diagnostics Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa HIV and AIDS Diagnostics Market Size (2021-2032)
- 11.2 Middle East & Africa HIV and AIDS Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa HIV and AIDS Diagnostics Market Size by Country (2021-2026)
- 11.4 Middle East & Africa HIV and AIDS Diagnostics Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Siemens Healthineers
- 12.1.1 Siemens Healthineers Company Information
- 12.1.2 Siemens Healthineers Business Overview
- 12.1.3 Siemens Healthineers Revenue in HIV and AIDS Diagnostics Business (2021-2026)
- 12.1.4 Siemens Healthineers HIV and AIDS Diagnostics Product Portfolio
- 12.1.5 Siemens Healthineers Recent Developments
- 12.2 Bio-Rad
- 12.2.1 Bio-Rad Company Information
- 12.2.2 Bio-Rad Business Overview
- 12.2.3 Bio-Rad Revenue in HIV and AIDS Diagnostics Business (2021-2026)
- 12.2.4 Bio-Rad HIV and AIDS Diagnostics Product Portfolio
- 12.2.5 Bio-Rad Recent Developments
- 12.3 Abbott Laboratories
- 12.3.1 Abbott Laboratories Company Information
- 12.3.2 Abbott Laboratories Business Overview
- 12.3.3 Abbott Laboratories Revenue in HIV and AIDS Diagnostics Business (2021-2026)
- 12.3.4 Abbott Laboratories HIV and AIDS Diagnostics Product Portfolio
- 12.3.5 Abbott Laboratories Recent Developments
- 12.4 OraSure TechnologieS
- 12.4.1 OraSure TechnologieS Company Information
- 12.4.2 OraSure TechnologieS Business Overview
- 12.4.3 OraSure TechnologieS Revenue in HIV and AIDS Diagnostics Business (2021-2026)
- 12.4.4 OraSure TechnologieS HIV and AIDS Diagnostics Product Portfolio
- 12.4.5 OraSure TechnologieS Recent Developments
- 12.5 F. Hoffmann-La Roche
- 12.5.1 F. Hoffmann-La Roche Company Information
- 12.5.2 F. Hoffmann-La Roche Business Overview
- 12.5.3 F. Hoffmann-La Roche Revenue in HIV and AIDS Diagnostics Business (2021-2026)
- 12.5.4 F. Hoffmann-La Roche HIV and AIDS Diagnostics Product Portfolio
- 12.5.5 F. Hoffmann-La Roche Recent Developments
- 12.6 Hologic
- 12.6.1 Hologic Company Information
- 12.6.2 Hologic Business Overview
- 12.6.3 Hologic Revenue in HIV and AIDS Diagnostics Business (2021-2026)
- 12.6.4 Hologic HIV and AIDS Diagnostics Product Portfolio
- 12.6.5 Hologic Recent Developments
- 12.7 Abbott
- 12.7.1 Abbott Company Information
- 12.7.2 Abbott Business Overview
- 12.7.3 Abbott Revenue in HIV and AIDS Diagnostics Business (2021-2026)
- 12.7.4 Abbott HIV and AIDS Diagnostics Product Portfolio
- 12.7.5 Abbott Recent Developments
- 12.8 Chembio Diagnostic Systems
- 12.8.1 Chembio Diagnostic Systems Company Information
- 12.8.2 Chembio Diagnostic Systems Business Overview
- 12.8.3 Chembio Diagnostic Systems Revenue in HIV and AIDS Diagnostics Business (2021-2026)
- 12.8.4 Chembio Diagnostic Systems HIV and AIDS Diagnostics Product Portfolio
- 12.8.5 Chembio Diagnostic Systems Recent Developments
- 12.9 BD
- 12.9.1 BD Company Information
- 12.9.2 BD Business Overview
- 12.9.3 BD Revenue in HIV and AIDS Diagnostics Business (2021-2026)
- 12.9.4 BD HIV and AIDS Diagnostics Product Portfolio
- 12.9.5 BD Recent Developments
- 12.10 Danaher Corporation
- 12.10.1 Danaher Corporation Company Information
- 12.10.2 Danaher Corporation Business Overview
- 12.10.3 Danaher Corporation Revenue in HIV and AIDS Diagnostics Business (2021-2026)
- 12.10.4 Danaher Corporation HIV and AIDS Diagnostics Product Portfolio
- 12.10.5 Danaher Corporation Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst